Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
Abstract Objective To compare the use of mirabegron with anticholinergics drugs for the treatment of overactive bladder (OB). Data Source Systematic searches were conducted in EMBASE, PUBMED, Cochrane, and LILACS databases from inception to September 2021. We included RCTs, women with clinically pro...
Saved in:
Main Authors: | Luisa Gracio Ferreira Sartori (Author), Bruno Monteiro Nunes (Author), Daniela Farah (Author), Leticia Maria de Oliveira (Author), Claudia Cristina Takano Novoa (Author), Marair Gracio Ferreira Sartori (Author), Marcelo Cunio Machado Fonseca (Author) |
---|---|
Format: | Book |
Published: |
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022) -
Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis
by: Michael Kennelly, et al.
Published: (2022) -
Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017) -
Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021) -
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
by: Shaw C, et al.
Published: (2023)